2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy And Planning 2018, 33: 528-538. PMID: 29529282, PMCID: PMC5894072, DOI: 10.1093/heapol/czy018.Peer-Reviewed Original Research
2012
Financing vaccinations – The South African experience
Blecher MS, Meheus F, Kollipara A, Hecht R, Cameron NA, Pillay Y, Hanna L. Financing vaccinations – The South African experience. Vaccine 2012, 30: c79-c86. PMID: 22939027, DOI: 10.1016/j.vaccine.2012.04.042.Peer-Reviewed Original ResearchConceptsNew vaccinesNew vaccinationsNational vaccination policyBurden of diseaseHealth Economic CriteriaNew generation vaccinesNational advisory groupDepartment of HealthRotavirus diarrheaPneumococcal diseaseVaccination policyVaccinationGeneration vaccinesVaccineGlobal guidelinesEarly introductionInitial donationNumber of livesDiseaseInternational expertsAdvisory GroupFivefold increaseHealthNational spendingMorbidity